Abstract
Procedural and technology-based advances in circulatory support have enabled an increased number of patients to receive percutaneous coronary intervention (PCI). Without these advances, many patients would not have been considered for the procedure because of their elevated risk for complications. This chapter describes transcatheter-based circulatory support devices in clinical use today as well as data that support their usage and suggested protocols.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Hurst JW. The first coronary angioplasty as described by Andreas Gruentzig. Am J Cardiol. 1986;57:185–6.
Gruntzig A. Transluminal dilatation of coronary-artery stenosis. Lancet. 1978;1:263.
Gruntzig AR, Senning A, Siegenthlaer WE. Nonoperative dilatation of coronary-artery stenosis. Percutaneous transluminal coronary angioplasty. N Engl J Med. 1979;301:61–8.
Kantrowitz A, Tjonneland S, Freed PS, et al. Initial clinical experience with intraaortic balloon pumping in cardiogenic shock. JAMA. 1968;203:135–40.
Talpins NL, Kripke DC, Goetz RH. Counterpulsation and intraaortic balloon pumping in cardiogenic shock. Circ Dynam Arch Surg. 1968;97:991–9.
Scheidt S, Wilner G, Mueller H, et al. Intraortic balloon pumping in cardiogenic shock. Report of a cooperative clinical trial. N Engl J Med. 1973;288:979–84.
Willerson JT, Curry GC, Watson JT, et al. Intra-aortic balloon counterpulsation in patients with cardiogenic shock, medically refractory heart failure, and/or recurrent ventricular tachycardia. Am J Med. 1975;58:183–91.
DeWood MA, Notske RN, Hensley GR, et al. Intra-aortic balloon counterpulsation with and without reperfusion for myocardial infarction shock. Circulation. 1980;61:1105–12.
Nanas JN, Moulopoulos SD. Counterpulsation: historical background, technical improvements, hemodynamic and metabolic effects. Cardiology. 1994;84:156–67.
Kern MJ. Cardiac support devices: intra-aortic balloon pump. In: The cardiac catheterization handbook. 4th ed. St. Louis: Mosby; 2003. p. 479–94.
Shawl FA, Domanski MJ, Hernandez TJ, et al. Emergency percutaneous cardiopulmonary bypass with cardiogenic shock from acute myocardial infarction. Am J Cardiol. 1989;64:967–70.
Vogel RA, Shawl FA, Tommaso CL, et al. Initial report of the national registry of elective cardiopulmonary bypass SUPPORTED coronary angioplasty. J Am Coll Cardiol. 1990;15:23–9.
Shawl FA, Domanski MJ, Punja S. Percutaneous cardiopulmonary bypass support in high risk patients undergoing percutaneous transluminal coronary angioplasty. Am J Cardiol. 1989;64:1258–63.
Lincoff AM, Popma JJ, Ellis SG, et al. Abrupt vessel closure complicating coronary angioplasty. Clinical, angiographic, and therapeutic profile. J Am Coll Cardiol. 1992;19:926–35.
Bauters C, Van Belle E, Lablanche JM et al. Predictive factors of primary success after coronary angioplasty. Arch Mal Coeur Vaiss. 1994 Feb; 87(2); 193–9
Meier B. Percutaneous coronary intervention. In: Topel EJ, editor. Textbook of cardiovascular medicine. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2002. p. 1665–76.
Brigouri C, Sardis C, Pagnotta P, et al. Elective versus provisional intra-aortic balloon pumping in high-risk percutaneous transluminal coronary angioplasty. Am Heart J. 2003;145:700–7.
Mishra S, Chu WC, Torguson R, et al. Role of prophylactic intra-aortic balloon pump in high-risk patients undergoing percutaneous coronary intervention. Am J Cardiol. 2006;98:608–12.
Stone GW, Marsalese D, Brodie BR, et al. A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. J Am Coll Cardiol. 1997;29:1459–67.
Mackensie DJ, Wagner WH, Kulber DA, et al. Vascular complications of the intra-aortic balloon pump. Am J Surg. 1992;164:517–21.
Cook L, Pillar B, McCord G, et al. Intra-aortic balloon pump complications: a five-year retrospective study of 283 patients. Heart Lung. 1999;28:195–202.
Cohen M, Dawson MS, Kopistansky C, et al. Sex and other predictors of intra-aortic balloon conterpulsation-related complications: prospective study of 1119 consecutive patients. Am Heart J. 2000;139:282–7.
Meisel S, Shocat M, Sheikha SA, et al. Utilization of low profile intraaortic balloon catheters inserted by the sheathless technique in acute cardiac patients: clinical efficacy with a very low complication rate. Clin Cardiol. 2004;27:600–4.
Vogel RA, Tommaso CL, Gundry SR. Initial experience with coronary angioplasty and aortic valvuloplasty using elective semi-percutaneous cardiopulmonary support. Am J Cardiol. 1988;62:811–3.
Phillips SJ, Zeff RH, Kongtahworn C, et al. Percutaneous cardiopulmonary bypass: application and indication for use. Ann Thorac Surg. 1989;47:121–3.
Vogel RA, Shawl FA, Tommasso CL, et al. Initial report of the national registry of elective cardiopulmonary bypass supported coronary angioplasty. J Am Coll Cardiol. 1990;15:23–9.
Schreiber TL, Kodali UR, O’Neill WW, et al. Comparison of acute results of prophylactic intraaortic balloon pumping with cardiopulmonary support for percutaneous transluminal coronary angioplasty (PTCA). Cathet Cardiovasc Diagn. 1998;45:115–9.
Cyrus T, Mathews SJ, Lasala JM, et al. Use of mechanical assist during high- risk PCI and STEMI with cardiogenic shock. Catheter Cardiovasc Interv. 2010;75:S1–6.
de Souza CF, de Souza BF, De Lima VC, et al. Percutaneous mechanical assistance for the failing heart. J Interv Cardiol. 2010;23:195–202.
Sjauw KD, Remmelink M, Baan JR, et al. Left ventricular unloading in acute ST-segment elevation myocardial infarction patients is safe and feasible and provides acute and sustained left ventricular recovery. J Am Coll Cardiol. 2008;51:1044–6.
Henriques JP, Remmelink M, Baan Jr J, et al. Safety and feasibility of elective high-risk percutaneous coronary intervention procedures with left ventricular support of the Impella® Recover 2.5. Am J Cardiol. 2006;97:990–2.
Dixon SR, Henriques JP, Mauri L, et al. A prospective feasibility trial investigating the use of the Impella® 2.5 System in patients undergoing high-risk percutaneous coronary intervention (the PROTECT I trial): initial U.S. experience. JACC Cardiovasc Interv. 2009;2:91–6.
Seyfarth M, Sibbing D, Bauer I, et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol. 2008;52:1584–8.
Cheng JM, den Uil CA, Hoeks SE, et al. Percutaneous left ventricular assist device vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. Eur Heart J. 2009;30:2102–8.
Pulido JN, Park SJ, Charenjit S, et al. Percutaneous left ventricular assist devices: clinical uses, future applications and anesthetic considerations. J Cardiothorac Vasc Anesth. 2010;24:478–86.
Aragon J, Lee MS, Kar S, et al. Percutaneous left ventricular assist device: “TandemHeartTM” for high-risk coronary intervention. Catheter Cardiovasc Interv. 2005;65:346–52.
Vranckx P, Meliga E, De Jaegere PP, et al. The TandemHeart™ percutaneous transseptal left ventricular assist device: a safeguard in high-risk percutaneous coronary interventions. The six-year Rotterdam experience. EuroIntervention. 2008;4:331–7.
Atiemo AD, Conte JV, Heldman AW. Resuscitation and recovery from acute right ventricular failure using a percutaneous right ventricular assist device. Catheter Cardiovasc Interv. 2006;68:78–82.
Prutkin JM, Strote JA, Stout KK. Percutaneous right ventricular assist device as support for cardiogenic shock due to right ventricular infarction. J Invasive Cardiol. 2008;20:E215–6.
Thiele H, Sick P, Boudriot E, et al. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J. 2005;26:1276–83.
Burkhoff D, Cohen H, Brunckhorst C, et al. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart™ percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J. 2006;152:469e1–4698.
Rajdev S, Krishnan P, Irani A, et al. Clinical application of prophylactic percutaneous left ventricular assist device (TandemHeart™) in high-risk percutaneous coronary intervention using an arterial preclosure technique: single-center experience. J Invasive Cardiol. 2008;20:67–72.
Al-Husami W, Yturralde F, Mohanty G, et al. Single-center experience with the TandemHeart™ percutaneous ventricular assist device to support patients undergoing high-risk percutaneous coronary intervention. J Invasive Cardiol. 2008;20:319–22.
Gibbons GH, Dzau VJ. The emerging concept of vascular remodeling. N Engl J Med. 1994;330:1431–8.
Schober A, Zercecke A. Chemokines in vascular remodeling. Thromb Haemost. 2007;97:730–7.
Mitchell RN, Libby P. Vascular remodeling in transplant vasculopathy. Circ Res. 2007;100:967–78.
Korshunov VA, Schwartz SM, Berk BC. Vascular remodeling: hemodynamic and biochemical mechanisms underlying Glagov’s phenomenon. Arterioscler Thromb Vasc Biol. 2007;27:1722–8.
Glagov S, Weisenberg E, Zarins CK, et al. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med. 1987;316:1371–5.
Bond MG, Adams MR, Bullock BC. Complicating factors in evaluating coronary artery atherosclerosis. Artery. 1981;9:21–9.
Bonthu S, Heistad DD, Chappel DA, et al. Atherosclerosis, vascular remodeling, and impairment of endothelium-dependent relaxation in genetically altered hyperlipidemic mice. Arterioscler Thromb Vasc Biol. 1997;17:2333–40.
Armstrong ML, Heistad DD, Marcus ML, et al. Structural and hemodynamic response of peripheral arteries of macque monkeys to atherogenic diet. Arteriosclerosis. 1985;5:336–46.
Courtman DW, Schwartz SM, Hart CE. Sequential injury of the rabbit abdominal aorta induces intramural coagulation and luminal narrowing independent of intimal mass: extrinsic pathway inhibition eliminates luminal narrowing. Circ Res. 1998;82:996–1006.
Cote G, Tardif JC, Lesperance J, et al. Effects of probucol on vascular remodeling after coronary angioplasty. Multivitamins and Probucol Study Group. Circulation. 1999;99:30–5.
Nobuyoshi M, Kimura T, Nosaka H, et al. Restenosis after successful transluminal coronary angioplasty: serial angiographic follow-up of 229 consecutive patients. J Am Coll Cardiol. 1988;12:616–23.
Tardif JC, Cote G, Lesperance J, et al. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty: multivitamins and Probucol Study Group. N Engl J Med. 1997;337:365–72.
Korbling M, Estrov Z. Adult stem cells for tissue repair: a new therapeutic concept? N Engl J Med. 2003;349:570–82.
Ross JJ, Hong Z, Willenbring Z, et al. Cytokine-induced differentiation of multipotent adult progenitor cells Into functional smooth muscle cells. J Clin Invest. 2006;116:3139–49.
Shober A. Chemokines in vascular dysfunction and remodeling. Arterioscler Thromb Vasc Biol. 2008;28:1950–9.
Schmauss D, Weis M. Cardiac allograft vasculopathy: recent developments. Circulation. 2008;17:2131–41.
Hasdai D, Berger PB, Battler A, Holmes Jr DR, editors. Cardiogenic shock: diagnosis and treatment. Totowa: Humana Press; 2002.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Das, G.S., Raveendran, G., Schultz, J.C. (2012). Acute Catheter-Based Mechanical Circulatory Support. In: Vlodaver, Z., Wilson, R., Garry, D. (eds) Coronary Heart Disease. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-1475-9_25
Download citation
DOI: https://doi.org/10.1007/978-1-4614-1475-9_25
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4614-1474-2
Online ISBN: 978-1-4614-1475-9
eBook Packages: MedicineMedicine (R0)